Schedule
of Significant Assets and Liabilities Measured at Fair Value on Recurring Basis
| | |
June
30, 2026 | |
| | |
Fair
value hierarchy | |
| | |
Level
1 | | |
Level
2 | | |
Level
3 | |
| Financial assets | |
| | | |
| | | |
| | |
| | |
| | | |
| | | |
| | |
| Investment in marketable securities | |
| - | | |
| 2 | | |
| - | |
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements (Unaudited)
U.S.
dollars in thousands (except share data and per share data)
Note
3 - Financial Instruments (Cont.)
| | |
December
31, 2025 | |
| | |
Fair
value hierarchy | |
| | |
Level
1 | | |
Level
2 | | |
Level
3 | |
| Financial
assets | |
| | | |
| | | |
| | |
| | |
| | | |
| | | |
| | |
| Investment in marketable securities
(*) | |
| - | | |
| 2 | | |
| - | |
| (*) | For
the six-month period and three months ended June 30, 2026 and 2025, the Company recognized
gain (based on quoted market prices with a discount due to security restrictions on MYCB
shares) of the marketable securities was $0.2, $0.2, $7 and $0.5 respectively. |
|